Citigroup
PLRX icon

Citigroup’s Pliant Therapeutics PLRX Stock Holding History

Citigroup’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,000
Closed -$387K – 5732
2024
Q1 		$387K Sell
26,000
-3,900
-13% -$64.3K ﹤0.01% 3707
2023
Q4 		$541K Buy
+29,900
New +$455K ﹤0.01% 3351

Other funds holding PLRX

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Bond & Devick Financial Network
Bond & Devick Financial Network St. Louis Park, Minnesota $414M AUM 11.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Citigroup's PLRX Position: Q3 2026 in Review

Citigroup opened a new position in Pliant Therapeutics (PLRX) in Q3 2026: 2,330 shares worth $2.52K. The stake represents ﹤0.01% of the portfolio and ranks #5466 among its holdings. This is a return to the name: Citigroup previously reported a position in PLRX as recently as Q3 2025.

Citigroup first reported a position in PLRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $3.18M in Q1 2024. 15 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Citigroup held 2,330 shares of Pliant Therapeutics worth $2.52K as of Q3 2026.
  • Pliant Therapeutics was a new Citigroup position in Q3 2026.
  • Pliant Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5466 holding.
  • Citigroup first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • Citigroup's Pliant Therapeutics position peaked at $3.18M in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.